The Francis Crick Institute
Browse

DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation.

Download (12.19 MB)
journal contribution
posted on 2025-12-04, 11:46 authored by Michael D Buck, Tomás Castro-Dopico, Oliver Schulz, Ana Cardoso, Probir Chakravarty, Nathalie Legrave, Conor M Henry, Johnathan Canton, Estelle Wu, Sonia Lee, Neil C Rogers, Enzo Z Poirier, William Stainier, Victor Bosteels, Eleanor Childs, James I MacRae, J Mark Skehel, Santiago Zelenay, Caetano Reis e Sousa
Innate immune receptors often induce activation of conventional dendritic cells (cDCs) and enhance antigen (cross-)presentation, favouring immune responses. DNGR-1 (CLEC9A), a receptor expressed by type 1 cDCs (cDC1s) and implicated in immune responses to viruses and cancer, recognises F-actin exposed on dead cell remnants and promotes cross-presentation of associated antigens. Here, we show that recruitment of phosphatase SHIP1, a process governed by a single amino acid residue adjacent to the signalling motif of the receptor, partly explains how DNGR-1 fails to trigger cDC1 activation in vitro. Substituting this residue converts DNGR-1 into an activating receptor but decreases induction of cross-presentation of dead cell-associated antigens. Introducing the reverse mutation into the related receptor Dectin-1 impairs its activation capacity while enhancing its ability to promote cross-presentation. These findings reveal a functional trade-off in receptor signalling and suggest that DNGR-1 has evolved to prioritise antigen cross-presentation over cellular activation, possibly to minimise inflammatory responses to dead cells.

Funding

Cancer Research UK (CRUK) (Grant ID: CC2090) Medical Research Council (MRC) (Grant ID: CC2090) Wellcome Trust (WT) (Grant ID: CC2090) Wellcome Trust (WT) (Grant ID: 106973/Z/15/Z) Wellcome Trust (WT) (Grant ID: 223136/Z/21/Z) EC | ERC | HORIZON EUROPE European Research Council (ERC) (Grant ID: AdG 268670) EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) (Grant ID: 837951) EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) (Grant ID: 792770) Crick (Grant ID: CC1063, Grant title: STP Proteomics) Crick (Grant ID: CC1067, Grant title: STP Metabolomics) Crick (Grant ID: CC1107, Grant title: STP Bioinformatics & Biostatistics) Crick (Grant ID: CC2090, Grant title: Reis e Sousa CC2090) Wellcome Trust (Grant ID: 106973/Z/15/Z, Grant title: WT 106973/Z/15/Z) Wellcome Trust (Grant ID: 223136/Z/21/Z, Grant title: WT 223136/Z/21/Z) European Commission (Grant ID: 837951 - DC Metabolism, Grant title: EC 837951 - DC Metabolism) European Commission (Grant ID: 792770 - ActinSensor, Grant title: EC 792770 - ActinSensor)

History